NCT00698373
Completed
Not Applicable
Evaluation of Thoracic Tumors With 18F-FMT and 8F-FDG PET-CT: A Clinicopathological Study
ConditionsNon-Small Cell Lung Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-Small Cell Lung Cancer
- Sponsor
- Gunma University
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional information for the preoperative diagnostic workup as compared with 18F-FDG PET. Tumor uptake of 18F-FMT was compared with several immunohistochemical markers including L-type amino acid transporter 1 (LAT1).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with indeterminate pulmonary nodule suspicious of lung cancer
Exclusion Criteria
- •Patients with other malignancies and those who had received cancer treatment within the past 5 years were excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis PatientSarcoidosisNCT00369980Gunma University
Completed
Not Applicable
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung CancerNon-Small Cell Lung CancerNCT00826033Gunma University
Completed
Not Applicable
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung CancerCarcinoma, Non-Small-Cell LungNCT00464282Gunma University
Recruiting
Phase 1
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast CancerAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaNCT06502691University of Washington22
Completed
Not Applicable
18F-FET PET/CT in the Management of GliomaGliomaNCT06563024Buddhist Tzu Chi General Hospital36